financetom
Business
financetom
/
Business
/
Edison International beats profit estimates on lower expenses, rate hikes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Edison International beats profit estimates on lower expenses, rate hikes
May 25, 2025 9:20 PM

April 29 (Reuters) - Edison International ( EIX ) beat

Wall Street estimates for first-quarter profit on Tuesday, as

the utility benefited from lower operating and interest expenses

and higher rates for its services.

Lower interest rates reduce borrowing costs for power

companies, which usually need more capital for expenses such as

maintaining and upgrading the electric grid.

Interest expenses at Edison fell 32.2% to $301 million in

the first quarter, while total operating expenses fell 56.2% to

$1.7 billion.

Power bills are expected to go up as fresh power supply

struggles to keep up with rising demand from AI data centers,

increased domestic manufacturing and extreme weather conditions

like wildfires.

Southern California Edison (SCE), Edison's unit, has been

facing multiple lawsuits which allege that its electrical

equipment started one of the major wildfires in the Los Angeles

area - the Eaton fire.

"We are working closely with state and county leaders and

the communities of Altadena and Malibu to rebuild

wildfire-impacted areas," CEO Pedro Pizarro said.

"Once constructed, SCE's grid hardening in these areas will

increase reliability and reduce the exposure of electrical

distribution infrastructure to high wind and other extreme

weather events" Pizarro added.

The company reaffirmed its full-year 2025 forecast for

adjusted earnings in a range of $5.94 per share to $6.34 per

share. Analysts have estimated them at $6.01 per share.

The Rosemead, California-based company posted an adjusted

profit of $1.37 per share for the quarter ended March 31,

compared with analysts' estimate of $1.20 per share, according

to data compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Harmonic Says VOS Media Software Gets Red Hat OpenShift Cloud-Native Network Function Certification
Harmonic Says VOS Media Software Gets Red Hat OpenShift Cloud-Native Network Function Certification
Apr 12, 2024
10:40 AM EDT, 04/12/2024 (MT Newswires) -- Harmonic (HLIT) said Friday its VOS Media Software achieved Red Hat OpenShift cloud-native network function certification. Red Hat OpenShift allows users to deploy video streaming and broadcast applications faster through reduced operational costs, Harmonic said. The company said that media companies and service providers can now deploy any VOS Media Software-powered video streaming...
Invivyd Names Jeremy Gowler as Interim CEO
Invivyd Names Jeremy Gowler as Interim CEO
Apr 12, 2024
10:30 AM EDT, 04/12/2024 (MT Newswires) -- Invivyd ( IVVD ) said Friday that Jeremy Gowler was named interim chief executive officer, effective immediately, succeeding Dave Hering. Gowler, 47. will remain as chief operating officer and chief commercial officer while serving in the interim position with the board looking for a permanent CEO, the company said in a regulatory filing....
AbbVie Says Phase 3 Interim Data Support Long-Term Efficacy, Safety of Migraine Drug
AbbVie Says Phase 3 Interim Data Support Long-Term Efficacy, Safety of Migraine Drug
Apr 12, 2024
10:43 AM EDT, 04/12/2024 (MT Newswires) -- AbbVie ( ABBV ) said Friday that interim data from an ongoing phase 3 extension study support the long-term safety, tolerability and efficacy of atogepant 60 mg to prevent chronic and episodic migraine. The company said 70% of the participants experienced at least 50% fewer migraine days each month after 13 to 16...
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
Apr 12, 2024
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has determined that there is no substantial evidence supporting a link between Glucagon-Like Peptide-1 receptor agonists (GLP-1) and suicidal or self-injurious thoughts and behaviors.  The assessment comes following reports of suicidal thoughts or actions. The FDA also conducted a review of GLP-1 RAs. The FDA released an update stating that its preliminary review did...
Copyright 2023-2026 - www.financetom.com All Rights Reserved